129 related articles for article (PubMed ID: 11798627)
1. [The effects of blocking intrarenal renin-angiotensin system on the expression of transforming growth factor-beta1 mRNA and extracellular matrix components].
Zhou C; Li J; Wang H
Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):44-6. PubMed ID: 11798627
[TBL] [Abstract][Full Text] [Related]
2. Renal protective effects of blocking the intrarenal renin-angiotensin system.
Li J; Zhou C; Yu L; Wang H
Hypertens Res; 1999 Sep; 22(3):223-8. PubMed ID: 10515446
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis.
Ji Z; Huang C; Liang C; Chen B; Chen S; Sun W
Cell Mol Immunol; 2005 Apr; 2(2):150-4. PubMed ID: 16191423
[TBL] [Abstract][Full Text] [Related]
4. Renin angiotensin system blockade ameliorates lead nephropathy.
Ng HY; Tain YL; Lee YT; Hsu CY; Chiou TT; Huang PC; Lee CT
Biochem Biophys Res Commun; 2013 Aug; 438(2):359-63. PubMed ID: 23896603
[TBL] [Abstract][Full Text] [Related]
5. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
[TBL] [Abstract][Full Text] [Related]
6. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta1 upregulation is independent of angiotensin in paraquat-induced lung fibrosis.
Chen CM; Chou HC; Hsu HH; Wang LF
Toxicology; 2005 Dec; 216(2-3):181-7. PubMed ID: 16182431
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
10. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis.
Gilbert RE; Wu LL; Kelly DJ; Cox A; Wilkinson-Berka JL; Johnston CI; Cooper ME
Am J Pathol; 1999 Aug; 155(2):429-40. PubMed ID: 10433936
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart.
Sun Y; Zhang JQ; Zhang J; Ramires FJ
J Mol Cell Cardiol; 1998 Aug; 30(8):1559-69. PubMed ID: 9737942
[TBL] [Abstract][Full Text] [Related]
12. Association of all-trans retinoic acid treatment with the renin-angiotensin aldosterone system expression in glomerulosclerosis rats.
Zhou TB; Wu WF; Qin YH; Yin SS
J Renin Angiotensin Aldosterone Syst; 2013 Dec; 14(4):299-307. PubMed ID: 23144044
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2).
Morales MG; Cabrera D; Céspedes C; Vio CP; Vazquez Y; Brandan E; Cabello-Verrugio C
Cell Tissue Res; 2013 Jul; 353(1):173-87. PubMed ID: 23673415
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells.
Zhou L; Xue H; Yuan P; Ni J; Yu C; Huang Y; Lu LM
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):e152-7. PubMed ID: 20590668
[TBL] [Abstract][Full Text] [Related]
16. Role of proteinuria in the regulation of renal renin-angiotensin system components in unilateral proteinuric rats.
Deelman LE; Navis G; de Boer E; Wietses M; de Zeeuw D; Henning RH
J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):38-42. PubMed ID: 12692752
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibition decreases growth factor expression in the neonatal rat kidney.
Yoo KH; Wolstenholme JT; Chevalier RL
Pediatr Res; 1997 Nov; 42(5):588-92. PubMed ID: 9357928
[TBL] [Abstract][Full Text] [Related]
18. Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes.
Sharma R; Sharma M; Reddy S; Savin VJ; Nagaria AM; Wiegmann TB
Front Biosci; 2006 Jan; 11():968-76. PubMed ID: 16146787
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats.
Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143
[TBL] [Abstract][Full Text] [Related]
20. Effect of all-trans retinoic acid treatment on prohibitin and renin-angiotensin-aldosterone system expression in hypoxia-induced renal tubular epithelial cell injury.
Zhou TB; Ou C; Rong L; Drummen GP
J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):243-9. PubMed ID: 25031298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]